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ARTICLE
The transcription-repair coupling factor Mfd
associates with RNA polymerase in the absence of
exogenous damage
Han N. Ho 1, Antoine M. van Oijen 1 & Harshad Ghodke 1
During transcription elongation, bacterial RNA polymerase (RNAP) can pause, backtrack or
stall when transcribing template DNA. Stalled transcription elongation complexes at sites of
bulky lesions can be rescued by the transcription terminator Mfd. The molecular mechanisms
of Mfd recruitment to transcription complexes in vivo remain to be elucidated, however.
Using single-molecule live-cell imaging, we show that Mfd associates with elongation tran-
scription complexes even in the absence of exogenous genotoxic stresses. This interaction
requires an intact RNA polymerase-interacting domain of Mfd. In the presence of drugs that
stall RNAP, we find that Mfd associates pervasively with RNAP. The residence time of Mfd
foci reduces from 30 to 18 s in the presence of endogenous UvrA, suggesting that UvrA
promotes the resolution of Mfd-RNAP complexes on DNA. Our results reveal that RNAP is
frequently rescued by Mfd during normal growth and highlight a ubiquitous house-keeping
role for Mfd in regulating transcription elongation.
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Transcription is a complex metabolic process in whichgenetic information encoded in double-strandedDNA (dsDNA) is transcribed by the RNA polymerase
(RNAP) to form RNA. In bacteria, this reaction is executed by the
bacterial RNAP composed of five subunits α2ββ′ω1. Whereas
these core proteins catalyse the templated addition of rNTPs to
the growing RNA chain, additional accessory factors are required
to initiate and execute successful rounds of transcription in cells.
The activities of these factors are coordinated to cycle RNAP
through the various stages of the transcription cycle, a process
that includes promoter recognition, closed complex formation,
open complex formation, abortive initiation, promoter escape,
elongation and termination2.
Far from being a highly processive reaction, transcription
elongation is punctuated by nucleotide mis-incorporations,
pausing or stalling events and collisions with template-bound
proteins acting as roadblocks3–6. These events may lead to tran-
scription elongation complexes (TECs) entering non-productive
states that leave it stalled on the DNA. As highly stable com-
plexes, failed TECs can pose a threat to cell survival. While in
some cases RNAP may be able to resume elongation unaided, in
Escherichia coli (E. coli) these stalled TECs are often rescued by
the concerted action of several transcription modulators such as
GreA/B7, NusA and UvrD8, and Mfd9. Depending on particular
transcription modulator(s) associated with the stalled RNAP,
RNAPs are led into various pathways including transcript clea-
vage and restart, or transcription termination by forward or
backward translocation. Understanding the interplay between
various regulatory factors that enable processive and high-fidelity
transcription has been an area of intense investigation and con-
tinues to be a long-standing challenge in the context of live
cells10–12.
In E. coli the transcription-repair coupling factor Mfd pro-
motes transcription termination at sites of stalled RNAP and
recruits the nucleotide excision repair (NER) machinery to the
site of the damage (reviewed in ref. 13). This transcription-
coupled repair (TCR) pathway occurs in the following manner:
first, Mfd binds the β subunit of stalled RNAP at the upstream
side of the transcription bubble14,15. Second, RNAP binding is
thought to promote a conformational change in Mfd that allows it
to bind dsDNA and trigger its translocase activities16. Third,
translocation along dsDNA results in the collapse of the tran-
scription bubble and enables dissociation of RNAP from the
template DNA, and the nascent transcript from RNAP17. In the
final step, the lesion is handed over from RNAP to the UvrAB
proteins that specifically recognize the DNA damage and coor-
dinate repair9.
Whereas the mechanism of TCR is reasonably well understood
from several in vitro studies, it is not clear how the different
partners interact in the intracellular environment, where multiple
DNA-repair factors often perform redundant functions. With the
objective of localizing and measuring the kinetics of association of
Mfd with RNAP in live cells, we constructed an MG1655 strain
carrying a chromosomal fusion of the bright fluorescent protein
YPet to the C-terminus of Mfd. We found that fluorescently
tagged Mfd retains the ability to complement transcription-
coupled NER in live cells when assayed for UV survival. Live-cell
imaging of growing bacteria revealed a pervasive association of
Mfd with the nucleoid even in the absence of exogenously
induced DNA damage. Using a combination of small-molecule
modulators of transcription and mutants of Mfd, we demonstrate
that this extensive association of Mfd with the nucleoid arises
primarily from interactions of Mfd with stalled TECs of RNAP.
These observations demonstrate that Mfd rescues stalled RNAPs
during normal metabolism, in the absence of externally inflicted
DNA damage. Based on our observations, we conclude that Mfd
serves a critical house-keeping role in regulating transcription
during normal growth.
Results
Visualization of Mfd in live E. coli cells. To visualize Mfd in live
E. coli, we employed λ Red recombination to create a C-terminal
chromosomal fusion of mfd with the gene for the bright yellow
fluorescent protein YPet18. This strain expresses the Mfd-YPet
fusion protein from its native promoter (Fig. 1a). To identify
whether the fusion protein retains the ability to facilitate the TCR
of UV-induced damage in live cells, we performed UV-survival
assays. Specifically, we compared growth rates of ΔrecA cells
carrying mfd, mfd-ypet or Δmfd in the MG1655 background after
exposure to 254-nm light (Fig. 1b). Ultraviolet light is a strong
inducer of the SOS DNA-damage response in bacterial cells.
Upon SOS, the expression of the UvrABD and Cho—DNA-repair
factors that execute the global genomic nucleotide-excision repair
pathway19—is upregulated20. The increase in copy number of
UvrA by approximately tenfold prioritizes the detection of UV
lesions via the global genomic NER pathway, consequently
masking the signal from TCR21. Therefore, we assayed for Mfd-
YPet function in UV-sensitive ΔrecA cells that do not exhibit SOS
induction in response to DNA damage. In this genetic back-
ground, mfd− cells have been demonstrated to be significantly
more UV-sensitive than mfd+ cells9. Following UV exposure,
mfd-ypet ΔrecA cells recovered at similar rates to mfd+ ΔrecA at
low doses (0 and 1 J m−2) while slight delays were observed at 2.5
and 5 J m−2 (Fig. 1b). On the other hand, Δmfd ΔrecA cells
exhibited delay in recovery at intermediate UV doses (1 and 2.5 J
m−2) and failed to recover upon exposure to 5 J m−2. These
results demonstrate that the C-terminal YPet fusion retains
function and is able to complement the repair of UV-induced
lesions.
Next, we performed live-cell imaging to visualize the
intracellular localization of Mfd. Cells expressing Mfd-YPet from
the native chromosomal locus (mfd-ypet) were grown in EZ-rich
defined medium and deposited on a silanized coverslip in a flow
cell. This setup enabled us to visualize fast growing cells in the
presence of fresh growth medium at 30 °C (Fig. 1c, Methods and
Supplementary Fig. 1). Illumination with 514-nm laser light
revealed high fluorescence signal in cells that was attributable to a
high concentration of Mfd-YPet. Relying on the single-molecule
sensitivity of our fluorescence imaging, we determined the copy
number of fluorescent Mfd-YPet in our strain using photo-
bleaching experiments. By measuring the initial fluorescence
intensity of the cells and dividing it by the average intensity of a
single YPet molecule, we were able to estimate the copy number
of Mfd-YPet to be 22 ± 5 per cell (mean ± s.d., 254 cells; see
Supplementary Fig. 2a−c and Supplementary Note 3). While the
copy number of Mfd is widely believed to be 500 copies per cell22,
mass spectrometry-based measurements have determined Mfd
abundance in E. coli MG1655 grown in LB medium to be 48 ± 5
copies per cell (mean ± s.d.)23. Our estimate is consistent with the
latter measurement and likely reflects an underestimate of the
true copy number of Mfd for two reasons. First, slow maturation
or mis-folding of the fluorophore will result in dark Mfd-YPet
molecules that are invisible in these assays24. Second, C-
terminally tagged Mfd may be expressed with lower efficiency
compared to wild-type Mfd. The slight delay in recovery of mfd-
ypet cells compared to mfd+ following exposure to UV doses of
2.5 and 5 J m−2 (Fig. 1b) may be attributable to a potentially
lower expression level of Mfd-YPet compared to that of untagged
Mfd in wild-type cells.
Consistent with its role as a DNA-repair factor, Mfd-YPet
displayed a nucleoid-associated signal25 (Fig. 1d and
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Supplementary Movie 1). The Mfd-YPet distribution was found
to be heterogeneous, with regions of high intensity, reminiscent of
the localizations of RNA polymerase in live bacterial cells26.
Additionally, these data revealed that Mfd-YPet forms foci in
these cells, suggesting that the localizations visualized in our
experiments arise out of multiple transient or stably bound Mfd
molecules interacting with the nucleoid.
Binding of Mfd is mediated via interactions with RNAP. We
next probed whether the Mfd-YPet foci visualized in our
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Fig. 2 Mfd-YPet associates with the nucleoid via interactions with RNA polymerase. Schematic describing the initial stages of transcription-coupled repair.
a Mfd is recruited to RNA polymerase stalled at bulky lesions (orange star) on the transcribed strand. The arrow indicates the direction of transcription
elongation by RNA polymerase. b Substitution of L499 residue with arginine (R) results in the mutant Mfd(L499R) that is unable to rescue stalled
transcription complexes. Fluorescence images of Δmfd cells expressing plasmid-based c wild-type Mfd-YPet or d mutant Mfd(L499R)-YPet. White arrows
highlight well-defined Mfd-YPet foci. Each image is an average projection of ten continuous 100-ms frames. Scale bar, 2 µm
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Fig. 1 Visualization of Mfd in live Escherichia coli. a Schematic of construction of mfd-ypet strain using λ Red recombination. The native gene is replaced by a
chromosomal mfd-ypet fusion under its native promoter. b The chromosomal mfd-ypet fusion allele retains function when assayed for UV-survival. Growth
curves of mfd+ ΔrecA (black), mfd-ypet ΔrecA (green) and Δmfd ΔrecA (magenta) following exposure to various doses of 254-nm light. N0 and N are the
numbers of cells at the beginning of the experiment and at the time of measurement respectively. Shaded error bars represent standard error of the mean
of two measurements, with each measurement being an average of two technical replicates. c Schematic of experimental setup for visualizing Mfd-YPet in
live cells. d Representative fluorescence image of mfd-ypet cells upon illumination with 514-nm light. Image is an average projection of ten continuous 100-
ms frames. Cell outlines (yellow) were drawn based on the bright-field image. Scale bar, 2 µm
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experiments represented associations of Mfd with RNAP on DNA
(Fig. 2a). This association could be demonstrated by visualizing
an Mfd mutant that is impaired in its interactions with RNAP
and unable to displace stalled RNAP. We selected the Mfd
(L499R) mutant as it has previously been demonstrated to be
deficient in interactions with the β-subunit of RNAP, while
retaining other functions such as DNA binding, nucleotide
binding and ATP hydrolysis14 (Fig. 2a, b). To that end, we
constructed a low-copy plasmid expressing Mfd(L499R)-YPet
under the native mfd promoter (Supplementary Note 2) and
imaged it in Δmfd cells. In control studies, we expressed wild-type
Mfd-YPet from the same low-copy plasmid, under its native
promoter (Supplementary Note 2). In these cells, the copy
numbers of Mfd-YPet and Mfd(L499R)-YPet were found to be
190 ± 40 (mean ± s.d., 232 cells) and 170 ± 40 (mean ± s.d., 183
cells) respectively (Supplementary Fig. 2d, e).
Live-cell imaging of cells expressing wild-type Mfd-YPet from
the plasmid reveals a similar localization pattern as Mfd-YPet
expressed from the chromosome, with defined foci in most cells
(Fig. 2c). On the other hand, Mfd(L499R)-YPet exhibited a
homogenous cytosolic distribution (Fig. 2c, d and Supplementary
Fig. 3a−c). These results suggested that Mfd(L499R)-YPet does
not bind stably to its substrates in live cells. Upon closer
examination, Mfd(L499R)-YPet was found to exhibit foci on the
100-ms timescale reflective of transient interactions (Supplemen-
tary Movie 2). The loss of defined foci upon the introduction of
the disruptive L499R mutation in the surface of the RNAP-
interacting domain suggests that the stable binding events
visualized in the experiments for wild-type Mfd arise primarily
from interactions with RNAP. Further, these results also
demonstrate that RNAP is the major substrate of Mfd in live
cells under conditions of normal growth.
Mfd primarily associates stably with elongating complexes. To
further probe the association of Mfd with RNAP, we used small-
molecule modulators of transcription that are known to interact
with specific conformations adopted by RNAP during the tran-
scription cycle. The anti-microbial drug rifampicin (Rif) has been
demonstrated to selectively target the bacterial transcription
initiation complex27. Binding of Rif to RNAP sterically blocks the
path of the nascent RNA and prevents transcription elongation
beyond three nucleotides27. By doing so, Rif selectively inhibits
the transition to TECs and does not influence the ability of RNAP
to bind promoters and form open complexes28,29. Since actively
elongating RNAP complexes are refractory to Rif, we treated cells
with Rif for 60 min, to ensure that any ongoing rounds of RNA
synthesis are terminated by 60 min and all TECs have been
removed. Visualization of Mfd-YPet in Rif-treated cells revealed a
homogenous distribution of the Mfd-YPet signal (Fig. 3b, c and
Supplementary Fig. 4).
To quantify binding events of single Mfd-YPet molecules, we
collected rapid-acquisition movies of Mfd-YPet cells. In this
format, we make use of the fact that single YPet molecules
stochastically return to the bright state after photobleaching26,30.
The imaging protocol can be divided into two phases: Phase I
corresponding to the decay in fluorescent signal caused by
photobleaching and Phase II corresponding to the reactivation
phase. In the first phase of imaging, the cellular YPet fluorescence
disappeared in the first 30 frames (equivalent to 3 s using 100-ms
frames) (Fig. 3a and Supplementary Movie 1). In Phase II (frames
31−50), single YPet molecules were observed to return to the
bright state (Fig. 3e, left panel, and Supplementary Movie 1). The
reduced cytosolic background enabled single Mfd-YPet molecules
to be imaged and tracked unambiguously. To quantify Mfd-YPet
binding upon treatment with Rif, we counted Mfd-YPet foci per
cell that could be tracked in consecutive frames for at least 200 ms
in Phase II (referred to as ‘sub-second foci’). The number of Mfd-
YPet sub-second foci reduced sevenfold (Fig. 3e, f) in Rif-treated
cells compared to untreated cells. These observations demonstrate
that the genome-wide, stable association of Mfd with the nucleoid
is largely lost when RNAP is unable to form elongating
complexes.
Interpreting the fluorescence foci as RNAP-associated Mfd
leads to the prediction that drugs promoting the stalling of TECs
should promote stable association of Mfd-YPet and thus increase
the lifetime of the foci. CBR703 is a prototypical member of a
class of RNAP inhibitors that inhibit nucleotide addition during
the catalytic step of transcription31. In this activity, it binds the β′
bridge helix interconnecting the two largest RNAP subunits and
promotes RNAP pausing32. Since Mfd is involved in recognizing
stalled or paused RNAPs, we expected that cells treated with
CBR703 would exhibit an increase in the number of Mfd-YPet
foci. Since the potency of CBR703 is greater in tolC mutants of E.
coli33, we visualized Mfd-YPet expressed from its chromosomal
locus in ΔtolC cells upon exposure to 75 µg per mL of CBR703
after 30 min of incubation in a flow cell. As expected, averages of
frames 1–10 (corresponding to a total of 1 s exposure time) in
Phase I of imaging revealed a greater number of Mfd-YPet foci
(Fig. 3d) as compared to untreated cells (Supplementary Fig. 5a
−c). Examination of foci detected in Phase II of imaging also
revealed a greater number of Mfd-YPet sub-second foci per cell
compared to untreated wild-type cells or Rif-treated cells (Fig. 3e,
f). Control experiments with Mfd(L499R)-YPet cells treated with
CBR703 confirmed that the greater number of CBR703-
dependent localizations do not arise out of an off-target effect
of drug treatment (Supplementary Fig. 5d). Additionally, we
detected a greater number of immobile RNA polymerase foci in
an MG1655 tolC mutant strain expressing fluorescently labelled
RNA polymerase following CBR703 treatment (Supplementary
Fig. 6). Collectively, our experiments confirm that Mfd associates
with TECs in live cells.
These observations leave two possibilities that describe
interactions of Mfd with TECs: either Mfd associates with RNAP
constitutively during transcription or Mfd associates with TECs
that are stalled. Wild-type Mfd-YPet cells exhibited a localization
that was a mixture of well-defined foci and diffuse cytosolic signal
suggesting that only a fraction of the population of Mfd is bound
to nucleoid-associated RNAP at any time, and that unbound Mfd
is diffusive in the cytosol (Fig. 3b). Upon treatment with Rif, the
Mfd signal associated with the nucleoid via interactions with
RNAP was lost due to the inability of RNAP to form TECs. Rif-
treated cells exhibit a largely homogenous Mfd signal distribution
(Fig. 3c). In the presence of CBR703 (Fig. 3d), we see this
equilibrium driven to the opposite extreme—a greater number of
Mfd-YPet foci are detected upon drug treatment, attributable to a
greater number of drug-stalled RNAPs. These results reveal that
under conditions of fast growth with several hundreds to
thousands of RNAP engaged with the nucleoid in transcription
elongation34,35, only a fraction of Mfd is associated with TECs.
Considering previous observations that Mfd plays a role in
rescuing stalled transcription complexes9 and the observation that
stable Mfd association with the nucleoid is enriched in the
presence of CBR703, we interpret the Mfd visualized in our
experiments as associated with stalled RNAPs.
Interactions of Mfd with TECs are long lived. DNA-repair
factors often possess multiple binding modes that enable specific
and non-specific interactions with their substrates36–38. There-
fore, we hypothesized that the Mfd-YPet population detected in
cells reflects sub-complexes of Mfd associated with RNAP during
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03790-z
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various stages of TCR. We set out to measure the residence times
of various sub-complexes of Mfd that occur in live cells. Tracking
single molecules of fusion proteins tagged with genetically
expressible fluorophores on long time scales in live cells is
challenging due to the poor photo-stability of fluorescent pro-
teins. To extend observation of bound molecules to the time scale
of several minutes, we employed an interval-based imaging
strategy that involves addition of dark frames between
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Fig. 3 Transcription inhibitors change Mfd-YPet binding frequency. a Mean cellular fluorescence intensity of a representative single mfd-ypet cell during a
5-s continuous acquisition in 514-nm channel (each green bar (top) represents a 100-ms frame). To visualize single molecules of Mfd-YPet, the cellular
fluorescence was first photobleached in a bleaching phase (Phase I; 3 s) followed by a photo-reactivation phase (Phase II; 2 s). Average projections of the
first ten frames in the bleaching phase (Phase I) of mfd-ypet cells b untreated or c rifampicin-treated (50 µg per mL, 60 min) and d mfd-ypet ΔtolC cells with
CBR703 treated (75 µg per mL, 30 min). e Montage of 100-ms frames during photo-reactivation phase from an mfd-ypet cell (untreated) or treated with
rifampicin, and an mfd-ypet ΔtolC cell treated with CBR703. f Bar plot representing the number of Mfd-YPet sub-second binding events detected in
untreated mfd-ypet cells (n= 1564 cells), cells treated with rifampicin (n= 396 cells), mfd-ypet ΔtolC untreated (n= 966 cells) and in CBR703 (n= 598
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acquisitions. This strategy has been recently used to interrogate
binding lifetimes of transcription factors and other DNA-
interacting proteins in live cells39–41 (Methods and Supplemen-
tary Note 4).
We employed the two-phase imaging strategy described before
with one important difference: in Phase II of imaging, we added
an additional dark period (τd) between two consecutive frames
(with integration time (τint) of 0.1 s) (Fig. 4a). In practice, we
collected several acquisitions of growing cells under identical
illumination conditions while changing the time-lapse time
(defined as τtime-lapse (τtl)= τd + τint) in the range from 0.1 to
10 s. The low cellular fluorescence in Phase II enabled us to
visualize and track bound, photo-reactivated Mfd-YPet molecules
unambiguously.
The residence times of individual foci detected in each
acquisition were measured and a cumulative residence time
distribution was generated (Fig. 4b, Methods and Supplementary
Table 4). This distribution describes the probability of a loss of a
fluorescent focus as a function of the time interval (in real time).
In our live-cell measurements, this cumulative residence time
distribution reflects the cumulative probability of two distinct
phenomena: the probability of dissociation of Mfd from the
RNAP-DNA complex or Mfd-RNAP complex from DNA, and
probability of loss of the focus due to photobleaching of the
fluorophore. Whereas the off-rate constant (koff) is characteristic
of the Mfd−RNAP interaction, the photobleaching rate constant
(kb) depends on the excitation intensity. Across data sets where
only the time-lapse time is varied, the photobleaching rate (in
frame time) is identical for all imaging conditions and can be de-
convoluted from the off rates as demonstrated previously39.
The cumulative residence time distributions were then fitted to
a single-exponential model to obtain effective off-rate constants
(keff) that represent mixtures of the photo-bleaching rate constant
(kb) and the off-rate constant (koff) (Methods and Supplementary
Note 4). In case of a two-state system, keffτtl and τtl follows a
linear relationship where the slope reveals koff for the state-
transition and the intercept provides kbτint (Methods, Supple-
mentary Note 4 and Supplementary Fig. 7)39. Linear least squares
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minimization of the Mfd-YPet data to a single off-rate model
revealed a koff equal to 0.056 ± 0.003 s−1, which corresponds to a
residence time of about 18 s (Fig. 4c and Supplementary Table 6).
Does this measured lifetime reflect an on-pathway intermediate
in TCR? Since UvrA is downstream of Mfd in the transcription-
coupled NER pathway, and has been shown to promote the
disassembly of Mfd-RNAP complexes42, we asked if the residence
time of Mfd in live cells is influenced by UvrA. We imaged mfd-
ypet ΔuvrA cells using the interval imaging approach described
above to measure the residence time of Mfd-YPet in the absence
of UvrA. Kinetic analysis of Mfd-YPet binding in ΔuvrA cells
revealed a single slowly dissociating species with a koff equal to
0.035 ± 0.004 s−1 (Fig. 4c and Supplementary Tables 5,6), or a
lifetime of nearly 30 s. In the presence of UvrA, the lifetime of
Mfd-YPet was almost twofold faster (18 s for uvrA+ cells),
demonstrating that UvrA (or a complex containing UvrA)
promotes dissociation of Mfd in cells. Taken together, these
experiments reveal that the 18 s lifetime of Mfd-YPet is governed
by interactions with RNAP as well as UvrA, signifying that the
repair intermediate described here corresponds to the lesion-
handover complex in transcription-coupled NER.
Mfd also associates at sites other than stalled TECs. One
intriguing observation from our experiments testing the associa-
tion of Mfd with RNAP is that approximately 14% of Mfd-YPet
foci (0.1 out of 0.7 binding events per cell, see Fig. 3f) remain in
Rif-treated cells. To better understand these interactions, we
imaged Mfd-YPet expressed from a low-copy plasmid in Δmfd
cells and quantified the number of Rif-sensitive and Rif-
insensitive foci observed in reactivation phase (Phase II, see
Methods). We counted the number of foci per cell that lasted for
either 200 ms (termed ‘sub-second’) or 1 s in real-time (two 100
ms exposures with a 900 ms dark interval, henceforth referred to
as ‘transient’). As described above, the Mfd-YPet concentration in
these cells is ninefold higher than that in mfd-ypet cells. In these
cells, Rif-treatment caused a 64% reduction in sub-second bind-
ing events per cell from 1.4 ± 0.7 to 0.5 ± 0.2 (Table 1 and Fig. 5a).
The twofold increase in the fraction of Rif-insensitive foci
(compare 14% to 36%) in response to a ninefold increase in Mfd-
YPet concentration indicates binding to a secondary substrate
that is dependent on the expression level of Mfd-YPet.
Could the Rif-insensitive foci visualized in these experiments
be attributable to dsDNA binding independent of RNAP?
Structural and small angle X-ray scattering studies have revealed
that Mfd normally adopts the auto-inhibited ‘closed’ state that
exists in a dynamic equilibrium with the ‘open’ state43.
Nucleotide binding promotes the formation of the open state
that exhibits robust dsDNA binding17,43,44. Additionally, trans-
location activity is stimulated by binding to stalled TECs16.
Therefore, to characterize DNA binding properties of Mfd in live
cells, we attempted to tip the conformational equilibrium to the
open state by introducing the E730Q mutation in the Walker B
motif43. Mfd(E730Q) has been demonstrated to be deficient in
ATP hydrolysis but not ATP binding, and exhibits similar
dsDNA binding properties as Mfd bound to ATPγS in the
absence of RNAP 43. When expressed from a low-copy plasmid
(140 ± 30 copies of Mfd(E730Q)-YPet per cell, see Supplementary
Fig. 2f and Supplementary Fig. 3d), the E730Q mutant exhibited
almost twofold more foci per cell than Mfd-YPet (sub-second
foci: 2.6 ± 0.4 vs. 1.4 ± 0.7; transient foci: 2.4 ± 0.5 vs. 1.0 ± 0.7, see
Table 1 and Fig. 5b). Following Rif-treatment, the frequency of
sub-second Mfd(E730Q)-YPet foci reduced inappreciably from
2.6 ± 0.4 to 2.0 ± 0.9 foci per cell (Table 1), whereas frequency of
transient foci remained unchanged from 2.4 ± 0.5 to 2.3 ± 1 foci
per cell. Significantly, Mfd(E730Q) exhibited almost sixfold
greater number of Rif-insensitive foci (compare transient binding
events in Table 1: 2.4 foci per cell for Mfd(E730Q) vs. 0.4 foci per
cell for wild-type Mfd). These experiments provide three findings:
1. Rif-insensitive foci can arise out of non-specific dsDNA
binding; 2. TECs are not favoured substrates for binding of Mfd
(E730Q) in vivo and 3. The ATP bound open configuration is not
the predominant state of wild-type Mfd in Rif-treated cells.
We then set out to characterize the extent of RNAP-
independent dsDNA binding of Mfd arising from stochastic
transitions to the open configuration in its dynamic equilibrium.
To that end, we probed the DNA binding ability of Mfd(L499R)-
YPet which does not bind RNAP, and consequently does not
exhibit long-lived foci (see Fig. 2). However, this mutant still
exhibited transient foci that could arise either out of weak
interactions with stalled TECs or from dsDNA binding. To assess
whether these transient associations arose out of weak interac-
tions with TECs, we imaged Mfd(L499R)-YPet in the presence of
Rif. Mfd(L499R)-YPet exhibited only 0.2 ± 0.1 sub-second foci
per cell in untreated cells (Table 1 and Fig. 5c). Moreover, Rif-
treatment did not influence frequency of sub-second Mfd
(L499R)-YPet binding, with 0.19 ± 0.04 foci per cell observed in
Rif-treated cells (Table 1). The frequency of transient foci per cell
was lower (0.09 ± 0.05 foci per cell, see Table 1) and similarly
insensitive to Rif-treatment (Fig. 5c), suggesting that Mfd(L499R)
interactions possess a sub-second lifetime. These experiments
allow us to rule out weak residual interactions with TECs as the
causes of focus formation by this mutant. Invoking the known
Table 1 Sub-second and transient foci per cell exhibited by Mfd-YPet and mutants in untreated and Rif-treated cells
Strain Mfd and
mutants
Copy
number
Sub-second foci per cell Transient foci per cell
Untreated Rif-treated Fraction of
Rif-
insensitive
foci (%)
Untreated Rif-treated Fraction of
Rif-
insensitive
foci (%)
mfd-ypet Mfd-YPet 22±5 0.70±0.04
(n=1564)
0.10±0.05
(n=396)
14 − − −
Δmfd Mfd-YPet 190±40 1.4±0.7 (n=313) 0.5±0.2 (n=430) 36 1.0±0.4 (n=319) 0.4±0.1 (n=544) 40
Δmfd Mfd(E730Q)-
YPet
140±30 2.6±0.4 (n=329) 2.0±0.9 (n=291) 77 2.4±0.5
(n=409)
2.3±1 (n=285) 96
Δmfd Mfd(L499R)-
YPet
170±40 0.2±0.1 (n=371) 0.19±0.04
(n=463)
95 0.11±0.02
(n=407)
0.09±0.05
(n=468)
82
Δmfd
ΔuvrA
Mfd-YPet 190±40 1.0±0.2 (n=223) 0.4±0.1 (n=317) 40 0.9±0.5 (n=242) 0.4±0.1 (n=390) 44
Fraction of Rif-insensitive foci is defined as the ratio of foci per cell in Rif-treated and untreated cells. Mean ± s.d. (three experiments). n, the number of cells.
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activities of Mfd, the simplest explanation for the Mfd(L499R)-
YPet foci is non-specific DNA binding.
However, this explanation alone cannot explain Mfd-YPet foci
observed during Rif-treatment. When expressed to similar levels,
Mfd-YPet forms between two- and fourfold more Rif-insensitive
foci than the Mfd(L499R)-YPet foci on either timescale (Table 1
and Fig. 5c), leaving at least 0.3 foci per cell unaccounted for in
cells expressing Mfd-YPet from the plasmid. We next investigated
whether Mfd-UvrA intermediates represent the Rif-insensitive
foci visualized in these experiments. Early experiments have
revealed that high concentrations of UvrA can inhibit TCR45,
presumably by forming off-pathway intermediates that cannot
engage TECs efficiently. Cytosolic Mfd exists in a dynamic
equilibrium between the auto-inhibited state and the open
configuration that can engage UvrA in the absence of stalled
TECs43. At higher Mfd concentrations, futile Mfd-UvrA2-Mfd/
UvrB intermediates could be formed, that would promote UvrA-
mediated Rif-independent DNA binding. We examined this
possibility by imaging plasmid-based Mfd-YPet in Δmfd ΔuvrA
cells. Deletion of uvrA led to a reduction in the frequency of Mfd-
YPet sub-second foci per cell in untreated cells (compare 1.4 ± 0.7
to 1.0 ± 0.2 foci per cell, see Table 1 and Fig. 5a, d). However, Rif-
treated cells exhibited a comparable frequency of Rif-sensitive foci
(compare 0.4 ± 0.1 uvrA− to 0.5 ± 0. 2 uvrA+, see Table 1 and
Fig. 5a, d). A model invoking an RNAP-independent, UvrA-
mediated association of Mfd-YPet with the nucleoid fails to
sufficiently explain the origins of the Rif-insensitive foci under
these conditions.
Discussion
In this work, we set out to visualize the first step of TCR. We
employed single-molecule imaging approaches using a fluores-
cently labelled C-terminal fusion of Mfd, to visualize and quantify
binding kinetics of Mfd in live cells. In the absence of external
DNA damaging agents, we anticipated infrequent or transient
associations of Mfd with RNAP in live cells, but were surprised to
find that Mfd exhibits a stable interaction that lasts for several
tens of seconds. Further investigation revealed that these stable
binding events arise out of bona fide interactions with RNAP and
UvrA. Four lines of evidence support this conclusion: first,
mutation of the RNAP-interacting surface as in Mfd(L499R)
results in the loss of long-lived foci. Second, 85% of Mfd foci in
mfd-ypet cells are lost when transcription elongation is abolished
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Fig. 5 Influence of rifampicin on binding of plasmid-based Mfd-YPet and mutants. Bar plots represent sub-second (green) and transient (blue) binding
events detected in a−c Δmfd cells expressing a Mfd-YPet, b Mfd(E730Q)-YPet and c Mfd(L499R)-YPet, and in d Δmfd ΔuvrA cells expressing Mfd-YPet.
Cells grew in the absence (Rif–) or presence of Rif (Rif+, 50 µL per mL) for 1 h in the flow cell prior to imaging. Error bars are standard deviations from three
experiments. a−c Cartoons illustrate the dynamic equilibrium of conformational states of Mfd and mutants. d The cartoon illustrates the hypothetical
complex UvrB-UvrA2-Mfd
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03790-z
8 NATURE COMMUNICATIONS |  (2018) 9:1570 | DOI: 10.1038/s41467-018-03790-z | www.nature.com/naturecommunications
in the presence of Rif. Third, treatment with CBR703—a drug
that stalls RNAP—results in an increased number of stable
binding events of Mfd. Finally, the lifetime of the stable inter-
actions of Mfd is regulated by UvrA.
To probe the nature of the interaction of Mfd with RNAP, we
treated cells with two small-molecule modulators of transcription
—CBR703 and Rif. CBR703-treated cells exhibited a threefold
greater number of stable Mfd foci demonstrating that CBR703-
stalled TECs are a target for Mfd. Rif-treatment of mfd-ypet cells
(22 copies of Mfd per cell) led to an 85% loss of foci. Cells
expressing Mfd-Ypet from a low copy plasmid (190 copies of
Mfd-YPet per cell) exhibited a 64% loss of foci upon Rif-
treatment. Stalled TECs thus represent the major substrate for
Mfd activity.
Next, we harnessed the sensitivity of our approach to measure
binding kinetics of Mfd in vivo. We employed an interval imaging
strategy that enabled us to accurately measure binding kinetics of
Mfd-YPet in growing cells. Mfd foci exhibited a mean lifetime of
18 s in the uvr+ background. In contrast, ΔuvrA cells exhibited
Mfd foci that dissociated with a mean lifetime of 30 s. By virtue of
being RNAP- as well as, UvrA-dependent, this repair inter-
mediate with an 18 s lifetime represents the lesion handover
complex—encompassing the various stages of TCR from sub-
strate recognition, RNAP displacement and lesion hand-over to
either UvrA2 or UvrA2B. These measurements correspond well
with previous measurements from in vitro single molecule
experiments that measure the lifetimes of the Mfd-RNAP and
Mfd-RNAP-UvrA(B) intermediates17,42. The identity of Mfd
intermediates that dissociate with a 30 s lifetime in ΔuvrA cells
remains less certain. These could potentially represent abortive
intermediates or translocating Mfd following RNAP displacement
where subsequent dissociation may occur stochastically46 or upon
encountering roadblocks42.
In addition to detecting binding of Mfd to stalled TECs, we
detected a small but significant fraction of binding events that
were Rif-insensitive and dependent on Mfd concentration. To
understand the origin of these binding events, we investigated two
possibilities: first, Mfd binds dsDNA non-specifically, and second,
Rif-insensitive binding events correspond to futile Mfd-UvrA2-
Mfd/UvrB intermediates. In a ΔuvrA background, the frequency
of Rif-insensitive Mfd binding events was found to be unchanged
compared to uvrA+. This finding allowed us to rule out non-
productive UvrA-mediated complexes as the source of the short-
lived interactions.
The observations of transient foci exhibited by the mutant Mfd
(L499R) suggest that Mfd can bind dsDNA independently of
RNAP in vivo. Mfd has been demonstrated to bind dsDNA
in vitro44. Assuming the extents of non-specific dsDNA binding
exhibited by wild-type Mfd and Mfd(L499R) are similar, an upper
limit for non-specific dsDNA binding displayed by Mfd can be
obtained from our experiments with Rif-treated cells. When
normalized for the copy number of Mfd (190 copies per cell) vs.
Mfd(L499R) (170 copies), 16% of sub-second foci could be
attributed to non-specific dsDNA binding. However, this expla-
nation still leaves 20% of the foci remain unaccounted for upon
Rif treatment.
Rif-treatment does not result in a complete inhibition of RNAP
association with the promoter28,29. A plausible source of these
Rif-insensitive foci is Mfd interacting with promoter-associated
transcription initiation complexes during Rif-treatment. Pull-
down assays have showed that Mfd can bind to both the core
RNAP and the holoenzyme (RNAP and σ subunit) with similar
affinities in the absence of DNA47,48. Structural alignment of the
RNAP initiation complex (PDB ID: 4YLN) with available struc-
tures of Thermus thermophilus TRCF (PDB ID: 3MLQ) and E.
coli Mfd (PDB ID: 2EYQ) suggests that σ70 and Mfd bind the
upstream face of RNAP14,49 in proximal, but non-overlapping
sites (Supplementary Fig. 8). Specifically, the residues of β subunit
(I117 K118 E11948,50) that are important for Mfd binding remain
exposed and may permit simultaneous or competitive occupation
of RNAP by σ70 and Mfd15. While the promoter-proximal
elongation complexes containing σ70 were shown to be resistant
to Mfd displacement15, these results do not rule out transient
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Stalled TEC
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d
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b
Fig. 6 Multi-layered regulation of Mfd activities in vivo. a In solution, Mfd
exists in a dynamic equilibrium between the closed state and the ATP-
bound open state that is capable of short-lived DNA binding. b An Mfd
mutant (E730Q) that is deficient in ATP hydrolysis exhibits non-specific
DNA binding. c Active TECs are not a target for Mfd activity. Black arrow
indicates the direction of TEC movement. d Stable association of Mfd and
TEC is trigged by stalled TECs and involves the RNAP-interacting domain of
Mfd. An Mfd mutant in which the RNAP-interacting domain is disrupted
(L499R) loses the ability to engage stalled TECs. e Binding of Mfd is
stimulated by stalled TECs, resulting in the formation of a long-lived
complex with a lifetime of 30 s in the absence of UvrA. f UvrA2 promotes
the dissociation of Mfd from DNA, such that repair intermediates exhibit a
lifetime of 18 s
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interactions between Mfd and RNAP-σ70 complex on DNA. The
extent to which σ70 and Mfd simultaneously bind initiation
complexes in vivo at promoter sites remains to be investigated.
Several elegant biochemical and structural investigations have
suggested a ‘spring-loaded’ mechanism of action for Mfd func-
tion14,16. Our in vivo investigations support this model in which
Mfd exists in a dynamic equilibrium between the closed, auto-
inhibited conformation and the open conformation that is cap-
able of DNA binding (Fig. 6a). The non-specific DNA binding of
Mfd(E730Q) in Rif-treated cells supports the case for such a
dynamic equilibrium, where ATP-bound Mfd(E730Q) is stabi-
lized in the open conformation (Fig. 6b). The trigger for this
spring-loaded mechanism is the binding of Mfd to stalled TECs
(Fig. 6c) via the RNAP-interacting domain (Fig. 6d), resulting in
the formation of the TEC bound open conformation in wild-type
Mfd (Fig. 6e). Finally, a repair complex containing UvrA pro-
motes dissociation of Mfd from DNA (Fig. 6f).
Methods
Strains and plasmids. All bacterial strains used were derivatives of E. coli K-12
MG1655. Strains were constructed using λ-Red recombination, P1 transduction or
obtained as listed in Supplementary Table 1. Plasmids carrying mfd promoter and
allele for Mfd-YPet or mutants are listed in Supplementary Table 2. Oligonu-
cleotides used in λ-Red recombination and cloning are listed in Supplementary
Table 3.
UV survival assay. ΔrecA (HH021), Δmfd ΔrecA (HH023) and mfd-ypet ΔrecA
(HH034) were streaked on Luria-Bertani (LB) plates and grown overnight at 37 °C
from −80 °C stocks. For each strain, cells from a single colony were incubated in 1
mL of LB liquid media in 2 mL microcentrifuge tubes, at 37 °C for 24 h and shaken
at 1000 rpm (Eppendorf ThermoMixer C, Eppendorf, Germany). 10 µL of the
stationary phase culture were used to inoculate 1 mL of LB liquid media, followed
by incubation for 2 h. Early exponential phase (OD600 0.2–0.3) cultures were then
centrifuged at 3000 × g (Eppendorf Microcentrifuge 5424, Eppendorf, Germany)
for 5 min at room temperature. The cell pellets were washed twice with 1 mL of 0.1
M MgSO4 solution. The pellets were resuspended in 0.1 M MgSO4 to obtain an
OD600 of 0.25.
20 µL (~ 4 × 106 cells) of cells were transferred to 96-well plates and irradiated
(Herolab UV-8 SL, Herolab, Germany) with 254 nm-UV light at doses of 0, 1, 2.5
and 5 J m−2 respectively. 5 µL (containing ~106 cells, N0) of the UV-irradiated cell
suspension were used to inoculate 15 mL of LB liquid media in 50 mL Falcon tubes
in duplicate and incubated at 37 °C with shaking at 200 rpm. OD600 was monitored
for every hour from 7 to 24 h. At each time point, the average was taken from two
technical replicates and converted to the total amounts of cells (N), assuming
OD600 of 1.0 corresponds to 8 × 108 cells per mL. From two independent
experiments, the mean ln(N/N0) and standard error of the mean were plotted in
Fig. 1b.
Flow-cell assembly. Live-cell imaging was performed in home-built flow cells as
described previously51. Briefly, the flow cell was assembled from a quartz top piece
(45 × 20 × 1mm, ProSciTech, Australia) and an APTES-treated glass coverslip
(24 × 50 mm, Australian Scientific) using double-sided sticky tape (3M). Coverslips
were functionalized by sonicating for 30 min with 5M KOH, followed by extensive
rinsing with Milli-Q water and incubating in solution of 5% (v/v) of APTES ((3-
aminopropyl)-triethoxysilane 98%, Alfa Aesar, USA) in Milli-Q water for 5 min.
The coverslips were then washed once with ethanol and sonicated in ethanol for 1
min. Finally, functionalized coverslips were washed with Milli-Q water and rapidly
dried with compressed nitrogen.
Cell culture for imaging. Cells were grown at 30 °C in EZ-rich defined media
(Teknova, CA, USA) supplemented with 0.2% (w/v) glucose. For experiments
involved plasmid-based expression of Mfd-YPet and mutants, spectinomycin (50
µg per mL, Sigma-Aldrich, USA) was added to the growth media. Cultures at early
exponential phase were loaded into a custom-built flow cell maintained at 30 °C.
Aerated growth media was supplied during the experiment at a rate of 30 µL per
min using a syringe pump (Adelab Scientific, Australia). For experiments involving
drug treatment, growth medium was supplemented with rifampicin (50 µg per mL,
Sigma-Aldrich, USA) or CBR703 (75 µg per mL, Thermo Fisher Scientific, UK).
The minimal inhibitory concentrations of rifampicin for E. coli K-12 and CBR703
for E. coli tolC− were determined to be 7 µg per mL and 14 µg per mL
respectively52.
Fluorescence microscope and imaging. Single-molecule fluorescence imaging
was performed with a custom-built microscope (Supplementary Fig. 1), operating
in HILO mode53. The microscope was constructed with an inverted microscope
body (Nikon Eclipse-Ti, Nikon, Japan) equipped with a 1.49 NA 100× objective
and a 512 × 512 pixel2 Photometrics Evolve CCD camera (Photometrics, Arizona,
USA). NIS-Elements equipped with JOBS module (Nikon, Japan) was used to
operate the microscope. Mfd-YPet and mutants were imaged with a 514-nm
Sapphire LP laser (150 mW max. output, Coherent, CA, USA), and ET535/30m
emission filter (Chroma, Vermont, USA). The operating laser power density
measured directly at the sample above the objective lens with the laser pointing up
was 71W cm−2. RpoC-PAmCherry was imaged by first activating using a 405-nm
OBIS laser (200 mW max. output, Coherent, CA, USA) followed by read-out using
a 568-nm Sapphire LP laser (200 mW max. output, Coherent, CA, USA). PAm-
Cherry emission was collected using a ET590lp filter (Chroma, Vermont, USA).
The operating power densities for 405-nm and 568-nm lasers were 25W cm−2 and
442W cm−2 respectively.
Continuous imaging was acquired at a rate of 10 fps for 5 or 15 s. Interval
imaging of Mfd-YPet (mfd-ypet uvrA+ and mfd-ypet ΔuvrA) was performed in two
phases. In the first phase, 50 frames were collected as rapid acquisitions at a frame
rate of 1/τint (τint= 0.1 s). In the second phase, 100 frames were collected at a frame
rate (1/τtl). Where τtl is the sum of the integration time (τint; 0.1 s) and a fixed dark
time (τd; τtl= τint+ τd). In each experiment, videos with varying τtl (ranging from
0.1 to 10 s, see Fig. 4b and Supplementary Tables 4,5) were acquired. To minimize
laser damage, we ensured that a new set of cells was imaged for each different value
of the parameter τtl. For measurements of sub-second or transient foci per cell
(Table 1 and Fig. 5), the two-phase imaging protocol was employed. The first phase
included 100-frame rapid acquisition (10 fps) while the second phase contained
100 frames (0.1 s each) acquired with τtl of 0.1 or 1 s.
RpoC-PAmCherry was activated with the 405-nm laser for 1 s, and rapid
acquisitions (10 fps) were acquired in 568-nm channel for 5 s (Supplementary
Fig. 6).
Image analysis. Image analysis was performed in Fiji54, using the Single Molecule
Biophysics plugins (available at https://github.com/SingleMolecule/smb-plugins).
Raw videos (nd2 format) were converted into TIF files using Bio-Formats plugin,
flattened with excitation beam profile as described previously51. Cell outlines were
drawn in MicrobeTracker55. For quantification of binding events, peaks were
detected in the reactivation phase (Fig. 3f: frames 31−50, Fig. 4b: frames 51−100,
Table 1 and Fig. 5: frames 101−200). Peaks were detected by first applying a
discoidal average filter (inner radius of one pixel, outer radius of three pixels), then
selecting pixels above the intensity threshold (mean+ 10× s.d.). Secondly, only
peaks with the full width at half maximum smaller than five pixels (530 nm) were
kept to reject broad cytosolic features. Peaks detected within two-pixel radius (213
nm) in consecutive frames were considered to belong to the same binding event.
Dissociation kinetics of Mfd. A cumulative residence time distribution of binding
events as a function of frame-time was compiled for each τtl from nine and ten
independent experiments for mfd-ypet uvrA+ and mfd-ypet ΔuvrA respectively
(Supplementary Tables 4,5). Frame-time was converted to real time using the
formula t= (n− 1)τtl with n being the number of frames for which a focus could
be detected at the same location (Fig. 4b). The effective off-rate constant keff,
representing a mixture of kb and koff, was obtained by fitting the cumulative
residence time distribution to a single-exponential model as in Eq. (1):
f1 tð Þ ¼ A exp keff tð Þ ¼ A exp  kb τint
τtl
þ koff
 
t
 
; ð1Þ
where A is the number of molecules, t is real time in seconds39. To determine
uncertainties in keffτtl, fitting was performed a thousand times on cumulative
residence time distributions derived from randomly selecting 80% of the binding
events (bootstrapping and single-exponential fitting using custom-written
MATLAB codes, MathWorks, USA).
Equation (1) can be rearranged to yield a linear relationship between keffτtl and
τtl (Eq. (2)):
keff τtl ¼ kbτint þ koff τtl: ð2Þ
Data availability. The data that support the findings of this study and the codes
used for data analysis are available from the corresponding author upon request.
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